Orchid Pharma gets EIR report from USFDA on inspection closure for Tamil Nadu plant

11 Apr 2016 Evaluate

Orchid Pharma has received the Establishment inspection report (EIR) from US Food and Drug Administration (USFDA) based on the successful inspection closure for the API manufacturing facility located at Alathur in Kancheepuram District, Tamil Nadu. The facility was inspected by USFDA in the month of August 2015.

Orchid Pharma is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.

Orchid Pharma Share Price

708.50 -1.70 (-0.24%)
20-Jan-2026 09:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1661.80
Dr. Reddys Lab 1166.00
Cipla 1387.50
Zydus Lifesciences 880.35
Lupin 2168.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×